Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Gynecol Oncol ; 110(3 Suppl 2): S55-9, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18667229

RESUMEN

PET imaging utilizes a dedicated camera system with multiple positron detector rings. PET/CT precisely aligns and combines metabolic PET mages with anatomical CT images, and is being increasingly preffered over PET scanning alone. FDG is the most widely used radiotracer in the management of cancer patients, and the prototypical PET/CT protocol used in other cancers can also be applied to the management of cervical carcinoma patients. The applications of PET/CT in cervical cancer patients include: assessing local tumor extension (information on metabolic tumor activity and possible endometrial involvement), evaluating pelvic nodal involvement (even in cases with negative CT or MRI studies), detection of distant metastases (PET/CT should be the first imaging technique used to evaluate extrapelvic disease before pelvic exenteration), radiation therapy planning (in patiens with PET scans positive for lymph nodes), identification of persistent/recurrent disease (especially in assessing response to neoadjuvant therapy and prognosis (with an inverse response-survival relationship.


Asunto(s)
Fluorodesoxiglucosa F18 , Radiofármacos , Neoplasias del Cuello Uterino/diagnóstico por imagen , Femenino , Humanos , Ganglios Linfáticos/diagnóstico por imagen , Metástasis Linfática , Estadificación de Neoplasias , Tomografía de Emisión de Positrones/métodos , Planificación de la Radioterapia Asistida por Computador , Neoplasias del Cuello Uterino/patología , Neoplasias del Cuello Uterino/radioterapia
2.
Crit Rev Oncol Hematol ; 98: 170-9, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26597015

RESUMEN

Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine tumor of the skin. Therapeutic approach is often unclear, and considerable controversy exists regarding MCC pathogenesis and optimal management. Due to its rising incidence and poor prognosis, it is imperative to establish the optimal therapy for both the tumor and the lymph node basin, and for treatment to include sentinel node biopsy. Sentinel node biopsy is currently the most consistent predictor of survival for MCC patients, although there are conflicting views and a lack of awareness regarding node management. Tumor and node management involve different specialists, and their respective decisions and interventions are interrelated. No effective systemic treatment has been made available to date, and therefore patients continue to experience distant failure, often without local failure. This review aims to improve multidisciplinary decision-making by presenting scientific evidence of the contributions of each team member implicated in MCC management. Following this review of previously published research, the authors conclude that multidisciplinary team management is beneficial for care, and propose a multidisciplinary decision algorithm for managing this tumor.


Asunto(s)
Algoritmos , Carcinoma de Células de Merkel/terapia , Terapia Combinada/métodos , Toma de Decisiones , Comunicación Interdisciplinaria , Neoplasias Cutáneas/terapia , Humanos , Ganglios Linfáticos/patología , Tumores Neuroendocrinos/terapia , Grupo de Atención al Paciente , Biopsia del Ganglio Linfático Centinela , Piel/patología , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA